John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

Restoration Hardware Holdings Inc (RH) Pops on Williams-Sonoma, Inc. (WSM) Buyout Chatter

By John Kilhefner, Senior Managing Editor, Lango Franchise

Restoration Hardware Holdings Inc (RH) is up on news that Williams-Sonoma, Inc. (WSM) may buy. Is that a wise move, or a desperate one?

Priceline Group Inc Is Going to Break $1,500! (PCLN)

By John Kilhefner, Senior Managing Editor, Lango Franchise

Priceline Group Inc (NASDAQ:PCLN) is growing earnings faster than its stock price, but competitors and industry challenges could hinder it.

Anavex Life Sciences Corp. (AVXL) Scores Big on Biogen Test

By John Kilhefner, Senior Managing Editor, Lango Franchise

Anavex (AVXL) stock is up more than 40% after Biogen (BIIB) announced it would test one of its compounds, but AVXL is still in the red for the year.

Tempur Sealy International Inc (TPX) Hits the Mat on Dismal Sales Forecast

By John Kilhefner, Senior Managing Editor, Lango Franchise

Tempur Sealy International Inc (TPX) is taking a 22% nosedive after revealing it expects a sales decline for the full year.

Kite Pharma Inc Scores Big on Positive Clinical Trial (KITE)

By John Kilhefner, Senior Managing Editor, Lango Franchise

Kite Pharma Inc (NASDAQ:KITE) and Juno Therapeutics (NASDAQ:JUNO) are both riding high on KITE's positive lymphoma therapy results. Here's what happened.

Load More